<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39459859</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>26</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Impact of Vaccination on Intra-Host Genetic Diversity of Patients Infected with SARS-CoV-2 Gamma Lineage.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1524</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v16101524</ELocationID><Abstract><AbstractText>The high transmissibility, rapid evolution, and immune escape of SARS-CoV-2 variants can influence the course of infection and, in turn, morbidity and mortality in COVID-19, posing a challenge in controlling transmission rates and contributing to the emergence and spread of new variants. Understanding the factors that shape viral genetic variation is essential for comprehending the evolution and transmission of SARS-CoV-2, especially in vaccinated individuals where immune response plays a role in the progression and spread of this disease. In this context, we evaluated the impact of immunity induced by the CoronaVac vaccine (Butantan/Sinovac) on intra-host genetic diversity, analyzing 118 whole-genome sequences of SARS-CoV-2 from unvaccinated and vaccinated patients infected with the Gamma variant. Vaccination with CoronaVac favors negative selection at the intra-host level in different genomic regions. It prevents greater genetic diversity of SARS-CoV-2, reinforcing the importance of vaccination in reducing the emergence of new mutations and virus transmission.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marques</LastName><ForeName>Beatriz de Carvalho</ForeName><Initials>BC</Initials><Identifier Source="ORCID">0000-0003-1512-0198</Identifier><AffiliationInfo><Affiliation>Laboratório de Pesquisas em Virologia, Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto 15090-000, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banho</LastName><ForeName>Cecília Artico</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Laboratório de Pesquisas em Virologia, Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto 15090-000, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sacchetto</LastName><ForeName>Lívia</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-9716-6899</Identifier><AffiliationInfo><Affiliation>Laboratório de Pesquisas em Virologia, Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto 15090-000, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Negri</LastName><ForeName>Andreia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Vigilância Epidemiológica, Secretaria de Saúde de São José do Rio Preto, São José do Rio Preto 15090-000, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasilakis</LastName><ForeName>Nikos</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-0708-3289</Identifier><AffiliationInfo><Affiliation>Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Vector-Borne and Zoonotic Diseases, University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nogueira</LastName><ForeName>Maurício Lacerda</ForeName><Initials>ML</Initials><Identifier Source="ORCID">0000-0003-1102-2419</Identifier><AffiliationInfo><Affiliation>Laboratório de Pesquisas em Virologia, Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto 15090-000, São Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vigilância Epidemiológica, Secretaria de Saúde de São José do Rio Preto, São José do Rio Preto 15090-000, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>1U01AI151807-20A1</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014644" MajorTopicYN="Y">Genetic Variation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="Y">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016679" MajorTopicYN="Y">Genome, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073336" MajorTopicYN="N">Whole Genome Sequencing</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Gamma lineage</Keyword><Keyword MajorTopicYN="N">breakthrough infections</Keyword><Keyword MajorTopicYN="N">negative selection</Keyword><Keyword MajorTopicYN="N">vaccination</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39459859</ArticleId><ArticleId IdType="pmc">PMC11512383</ArticleId><ArticleId IdType="doi">10.3390/v16101524</ArticleId><ArticleId IdType="pii">v16101524</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Volz E., Mishra S., Chand M., Barrett J.C., Johnson R., Geidelberg L., Hinsley W.R., Laydon D.J., Dabrera G., O’Toole Á., et al. Assessing Transmissibility of SARS-CoV-2 Lineage B.1.1.7 in England. Nature. 2021;593:266–269. doi: 10.1038/s41586-021-03470-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03470-x</ArticleId><ArticleId IdType="pubmed">33767447</ArticleId></ArticleIdList></Reference><Reference><Citation>Tegally H., Wilkinson E., Giovanetti M., Iranzadeh A., Fonseca V., Giandhari J., Doolabh D., Pillay S., San E.J., Msomi N., et al. Detection of a SARS-CoV-2 Variant of Concern in South Africa. Nature. 2021;592:438–443. doi: 10.1038/s41586-021-03402-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03402-9</ArticleId><ArticleId IdType="pubmed">33690265</ArticleId></ArticleIdList></Reference><Reference><Citation>Faria N.R., Mellan T.A., Whittaker C., Claro I.M., da Candido D.S., Mishra S., E Crispim M.A., S Sales F.C., Hawryluk I., McCrone J.T., et al. Genomics and Epidemiology of the P.1 SARS-CoV-2 Lineage in Manaus, Brazil. Science. 2021;372:815–821. doi: 10.1126/science.abh2644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abh2644</ArticleId><ArticleId IdType="pmc">PMC8139423</ArticleId><ArticleId IdType="pubmed">33853970</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascarella S., Ciccozzi M., Zella D., Bianchi M., Benedetti F., Benvenuto D., Broccolo F., Cauda R., Caruso A., Angeletti S., et al. SARS-CoV-2 B.1.617 Indian Variants: Are Electrostatic Potential Changes Responsible for a Higher Transmission Rate? J. Med. Virol. 2021;93:6551–6556. doi: 10.1002/jmv.27210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27210</ArticleId><ArticleId IdType="pmc">PMC8426736</ArticleId><ArticleId IdType="pubmed">34260088</ArticleId></ArticleIdList></Reference><Reference><Citation>Viana R., Moyo S., Amoako D.G., Tegally H., Scheepers C., Althaus C.L., Anyaneji U.J., Bester P.A., Boni M.F., Chand M., et al. Rapid Epidemic Expansion of the SARS-CoV-2 Omicron Variant in Southern Africa. Nature. 2022;603:679–686. doi: 10.1038/s41586-022-04411-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04411-y</ArticleId><ArticleId IdType="pmc">PMC8942855</ArticleId><ArticleId IdType="pubmed">35042229</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H., Rao Z. Structural Biology of SARS-CoV-2 and Implications for Therapeutic Development. Nat. Rev. Microbiol. 2021;19:685–700. doi: 10.1038/s41579-021-00630-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-021-00630-8</ArticleId><ArticleId IdType="pmc">PMC8447893</ArticleId><ArticleId IdType="pubmed">34535791</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashte S., Gulbake A., El-Amin S.F., Gupta A. COVID-19 Vaccines: Rapid Development, Implications, Challenges and Future Prospects. Hum. Cell. 2021;34:711–733. doi: 10.1007/s13577-021-00512-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13577-021-00512-4</ArticleId><ArticleId IdType="pmc">PMC7937046</ArticleId><ArticleId IdType="pubmed">33677814</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R., Liu J., Zhang H. The Challenge of Emerging SARS-CoV-2 Mutants to Vaccine Development. J. Genet. Genom. 2021;48:102–106. doi: 10.1016/j.jgg.2021.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jgg.2021.03.001</ArticleId><ArticleId IdType="pmc">PMC8056881</ArticleId><ArticleId IdType="pubmed">33994322</ArticleId></ArticleIdList></Reference><Reference><Citation>Banho C.A., Sacchetto L., Campos G.R.F., Bittar C., Possebon F.S., Ullmann L.S., Marques B.d.C., da Silva G.C.D., Moraes M.M., Parra M.C.P., et al. Impact of SARS-CoV-2 Gamma Lineage Introduction and COVID-19 Vaccination on the Epidemiological Landscape of a Brazilian City. Commun. Med. 2022;2:41. doi: 10.1038/s43856-022-00108-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43856-022-00108-5</ArticleId><ArticleId IdType="pmc">PMC9053258</ArticleId><ArticleId IdType="pubmed">35603276</ArticleId></ArticleIdList></Reference><Reference><Citation>Hacisuleyman E., Hale C., Saito Y., Blachere N.E., Bergh M., Conlon E.G., Schaefer-Babajew D.J., DaSilva J., Muecksch F., Gaebler C., et al. Vaccine Breakthrough Infections with SARS-CoV-2 Variants. N. Engl. J. Med. 2021;384:2212–2218. doi: 10.1056/NEJMoa2105000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2105000</ArticleId><ArticleId IdType="pmc">PMC8117968</ArticleId><ArticleId IdType="pubmed">33882219</ArticleId></ArticleIdList></Reference><Reference><Citation>Estofolete C.F., Banho C.A., Campos G.R.F., Marques B.C., Sacchetto L., Ullmann L.S., Possebon F.S., Machado L.F., Syrio J.D., Araújo Junior J.P., et al. Case Study of Two Post Vaccination SARS-CoV-2 Infections with P1 Variants in Coronavac Vaccinees in Brazil. Viruses. 2021;13:1237. doi: 10.3390/v13071237.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13071237</ArticleId><ArticleId IdType="pmc">PMC8309964</ArticleId><ArticleId IdType="pubmed">34206727</ArticleId></ArticleIdList></Reference><Reference><Citation>Karamitros T., Papadopoulou G., Bousali M., Mexias A., Tsiodras S., Mentis A. SARS-CoV-2 Exhibits Intra-Host Genomic Plasticity and Low-Frequency Polymorphic Quasispecies. J. Clin. Virol. 2020;131:104585. doi: 10.1016/j.jcv.2020.104585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104585</ArticleId><ArticleId IdType="pmc">PMC7418792</ArticleId><ArticleId IdType="pubmed">32818852</ArticleId></ArticleIdList></Reference><Reference><Citation>Lythgoe K.A., Hall M., Ferretti L., de Cesare M., MacIntyre-Cockett G., Trebes A., Andersson M., Otecko N., Wise E.L., Moore N., et al. SARS-CoV-2 within-Host Diversity and Transmission. Science. 2021;372:eabg0821. doi: 10.1126/science.abg0821.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abg0821</ArticleId><ArticleId IdType="pmc">PMC8128293</ArticleId><ArticleId IdType="pubmed">33688063</ArticleId></ArticleIdList></Reference><Reference><Citation>Armero A., Berthet N., Avarre J.C. Intra-Host Diversity of Sars-Cov-2 Should Not Be Neglected: Case of the State of Victoria, Australia. Viruses. 2021;13:133. doi: 10.3390/v13010133.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13010133</ArticleId><ArticleId IdType="pmc">PMC7833370</ArticleId><ArticleId IdType="pubmed">33477885</ArticleId></ArticleIdList></Reference><Reference><Citation>Voloch C.M., Da Silva Francisco R., De Almeida L.G.P., Brustolini O.J., Cardoso C.C., Gerber A.L., Guimarães A.P.D.C., Leitão I.D.C., Mariani D., Ota V.A., et al. Intra-Host Evolution during SARS-CoV-2 Prolonged Infection. Virus Evol. 2021;7:veab078. doi: 10.1093/ve/veab078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veab078</ArticleId><ArticleId IdType="pmc">PMC8500031</ArticleId><ArticleId IdType="pubmed">34642605</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu H., Quadeer A.A., Krishnan P., Ng D.Y.M., Chang L.D.J., Liu G.Y.Z., Cheng S.M.S., Lam T.T.Y., Peiris M., McKay M.R., et al. Within-Host Genetic Diversity of SARS-CoV-2 Lineages in Unvaccinated and Vaccinated Individuals. Nat. Commun. 2023;14:1793. doi: 10.1038/s41467-023-37468-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-37468-y</ArticleId><ArticleId IdType="pmc">PMC10063955</ArticleId><ArticleId IdType="pubmed">37002233</ArticleId></ArticleIdList></Reference><Reference><Citation>OSANG HEALTHCARE  GeneFinderTM COVID-19 Fast RealAmp Kit.  [(accessed on 24 November 2023)].  Available online:  https://www.osanghc.com/en/products_en/molecular-diagnosis/#.</Citation></Reference><Reference><Citation>Brabaham Bioinformatics FastQC  A Quality Control Tool for High Throughput Sequence Data.  [(accessed on 24 November 2023)].  Available online:  https://www.bioinformatics.babraham.ac.uk/projects/fastqc/</Citation></Reference><Reference><Citation>Martin M. Cutadapt Removes Adapter Sequences from High-Throughput Sequencing Reads. EMBnet. J. 2011;17:10–12. doi: 10.14806/ej.17.1.200.</Citation><ArticleIdList><ArticleId IdType="doi">10.14806/ej.17.1.200</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Durbin R. Fast and Accurate Short Read Alignment with Burrows-Wheeler Transform. Bioinformatics. 2009;25:1754–1760. doi: 10.1093/bioinformatics/btp324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp324</ArticleId><ArticleId IdType="pmc">PMC2705234</ArticleId><ArticleId IdType="pubmed">19451168</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H. A Statistical Framework for SNP Calling, Mutation Discovery, Association Mapping and Population Genetical Parameter Estimation from Sequencing Data. Bioinformatics. 2011;27:2987–2993. doi: 10.1093/bioinformatics/btr509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btr509</ArticleId><ArticleId IdType="pmc">PMC3198575</ArticleId><ArticleId IdType="pubmed">21903627</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellano S., Cestari F., Faglioni G., Tenedini E., Marino M., Artuso L., Manfredini R., Luppi M., Trenti T., Tagliafico E. Ivar, an Interpretation-oriented Tool to Manage the Update and Revision of Variant Annotation and Classification. Genes. 2021;12:384. doi: 10.3390/genes12030384.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes12030384</ArticleId><ArticleId IdType="pmc">PMC8001268</ArticleId><ArticleId IdType="pubmed">33800487</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Toole Á., Scher E., Underwood A., Jackson B., Hill V., McCrone J.T., Colquhoun R., Ruis C., Abu-Dahab K., Taylor B., et al. Assignment of Epidemiological Lineages in an Emerging Pandemic Using the Pangolin Tool. Virus Evol. 2021;7:veab064. doi: 10.1093/ve/veab064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veab064</ArticleId><ArticleId IdType="pmc">PMC8344591</ArticleId><ArticleId IdType="pubmed">34527285</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilm A., Aw P.P.K., Bertrand D., Yeo G.H.T., Ong S.H., Wong C.H., Khor C.C., Petric R., Hibberd M.L., Nagarajan N. LoFreq: A Sequence-Quality Aware, Ultra-Sensitive Variant Caller for Uncovering Cell-Population Heterogeneity from High-Throughput Sequencing Datasets. Nucleic Acids Res. 2012;40:11189–11201. doi: 10.1093/nar/gks918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks918</ArticleId><ArticleId IdType="pmc">PMC3526318</ArticleId><ArticleId IdType="pubmed">23066108</ArticleId></ArticleIdList></Reference><Reference><Citation>Cingolani P., Platts A., Wang L.L., Coon M., Nguyen T., Wang L., Land S.J., Lu X., Ruden D.M. A Program for Annotating and Predicting the Effects of Single Nucleotide Polymorphisms, SnpEff: SNPs in the Genome of Drosophila Melanogaster Strain W1118; Iso-2; Iso-3. Fly. 2012;6:80–92. doi: 10.4161/fly.19695.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/fly.19695</ArticleId><ArticleId IdType="pmc">PMC3679285</ArticleId><ArticleId IdType="pubmed">22728672</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team  R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna.  [(accessed on 24 November 2023)].  Available online:  https://www.R-project.org.</Citation></Reference><Reference><Citation>Wickham H., Chang W., Henry L., Pedersen T.L., Takahashi K., Wilke C., Woo K., Yutani H., Dunnington D. Ggplot2: Elegant Graphics for Data Analysis.  [(accessed on 24 November 2023)].  Available online:  https://ggplot2.tidyverse.org/</Citation></Reference><Reference><Citation>Kosakovsky Pond S.L., Frost S.D.W. Not so Different after All: A Comparison of Methods for Detecting Amino Acid Sites under Selection. Mol. Biol. Evol. 2005;22:1208–1222. doi: 10.1093/molbev/msi105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msi105</ArticleId><ArticleId IdType="pubmed">15703242</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosakovsky Pond S.L., Poon A.F.Y., Velazquez R., Weaver S., Hepler N.L., Murrell B., Shank S.D., Magalis B.R., Bouvier D., Nekrutenko A., et al. HyPhy 2.5—A Customizable Platform for Evolutionary Hypothesis Testing Using Phylogenies. Mol. Biol. Evol. 2020;37:295–299. doi: 10.1093/molbev/msz197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msz197</ArticleId><ArticleId IdType="pmc">PMC8204705</ArticleId><ArticleId IdType="pubmed">31504749</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvey W.T., Carabelli A.M., Jackson B., Gupta R.K., Thomson E.C., Harrison E.M., Ludden C., Reeve R., Rambaut A., Peacock S.J., et al. SARS-CoV-2 Variants, Spike Mutations and Immune Escape. Nat. Rev. Microbiol. 2021;19:409–424. doi: 10.1038/s41579-021-00573-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-021-00573-0</ArticleId><ArticleId IdType="pmc">PMC8167834</ArticleId><ArticleId IdType="pubmed">34075212</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D., Dejnirattisai W., Supasa P., Liu C., Mentzer A.J., Ginn H.M., Zhao Y., Duyvesteyn H.M.E., Tuekprakhon A., Nutalai R., et al. Evidence of Escape of SARS-CoV-2 Variant B.1.351 from Natural and Vaccine-Induced Sera. Cell. 2021;184:2348–2361.e6. doi: 10.1016/j.cell.2021.02.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.02.037</ArticleId><ArticleId IdType="pmc">PMC7901269</ArticleId><ArticleId IdType="pubmed">33730597</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontanet A., Cauchemez S. COVID-19 Herd Immunity: Where Are We? Nat. Rev. Immunol. 2020;20:583–584. doi: 10.1038/s41577-020-00451-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-00451-5</ArticleId><ArticleId IdType="pmc">PMC7480627</ArticleId><ArticleId IdType="pubmed">32908300</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercatelli D., Giorgi F.M. Geographic and Genomic Distribution of SARS-CoV-2 Mutations. Front. Microbiol. 2020;11:1800. doi: 10.3389/fmicb.2020.01800.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.01800</ArticleId><ArticleId IdType="pmc">PMC7387429</ArticleId><ArticleId IdType="pubmed">32793182</ArticleId></ArticleIdList></Reference><Reference><Citation>Jena D., Ghosh A., Jha A., Prasad P., Raghav S.K. Impact of Vaccination on SARS-CoV-2 Evolution and Immune Escape Variants. Vaccine. 2024;42:126153. doi: 10.1016/j.vaccine.2024.07.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2024.07.054</ArticleId><ArticleId IdType="pubmed">39060204</ArticleId></ArticleIdList></Reference><Reference><Citation>Plante J.A., Liu Y., Liu J., Xia H., Johnson B.A., Lokugamage K.G., Zhang X., Muruato A.E., Zou J., Fontes-Garfias C.R., et al. Spike Mutation D614G Alters SARS-CoV-2 Fitness. Nature. 2021;592:116–121. doi: 10.1038/s41586-020-2895-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2895-3</ArticleId><ArticleId IdType="pmc">PMC8158177</ArticleId><ArticleId IdType="pubmed">33106671</ArticleId></ArticleIdList></Reference><Reference><Citation>Magazine N., Zhang T., Wu Y., McGee M.C., Veggiani G., Huang W. Mutations and Evolution of the SARS-CoV-2 Spike Protein. Viruses. 2022;14:640. doi: 10.3390/v14030640.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14030640</ArticleId><ArticleId IdType="pmc">PMC8949778</ArticleId><ArticleId IdType="pubmed">35337047</ArticleId></ArticleIdList></Reference><Reference><Citation>Saldivar-Espinoza B., Garcia-Segura P., Novau-Ferré N., Macip G., Martínez R., Puigbò P., Cereto-Massagué A., Pujadas G., Garcia-Vallve S. The Mutational Landscape of SARS-CoV-2. Int. J. Mol. Sci. 2023;24:9072. doi: 10.3390/ijms24109072.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24109072</ArticleId><ArticleId IdType="pmc">PMC10219494</ArticleId><ArticleId IdType="pubmed">37240420</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmonds P. Rampant C→U Hypermutation in the Genomes of SARS-CoV-2 and Other Coronaviruses: Causes and Consequences for Their Short- and Long-Term Evolutionary Trajectories. mSphere. 2020;5:10–1128. doi: 10.1128/mSphere.00408-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mSphere.00408-20</ArticleId><ArticleId IdType="pmc">PMC7316492</ArticleId><ArticleId IdType="pubmed">32581081</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung S., Liu D.X. Human Coronavirus: Host-Pathogen Interaction. Annu. Rev. Microbiol. 2019;73:529–557. doi: 10.1146/annurev-micro-020518-115759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-micro-020518-115759</ArticleId><ArticleId IdType="pubmed">31226023</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giorgio S., Martignano F., Gabriella Torcia M., Mattiuz G., Conticello S.G. Evidence for Host-Dependent RNA Editing in the Transcriptome of SARS-CoV-2. Sci. Adv. 2020;6:eabb5813. doi: 10.1126/sciadv.abb5813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abb5813</ArticleId><ArticleId IdType="pmc">PMC7299625</ArticleId><ArticleId IdType="pubmed">32596474</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes A.L., Hughes M.A.K. More Effective Purifying Selection on RNA Viruses than in DNA Viruses. Gene. 2007;404:117–125. doi: 10.1016/j.gene.2007.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2007.09.013</ArticleId><ArticleId IdType="pmc">PMC2756238</ArticleId><ArticleId IdType="pubmed">17928171</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghafari M., Du Plessis L., Raghwani J., Bhatt S., Xu B., Pybus O.G., Katzourakis A. Purifying Selection Determines the Short-Term Time Dependency of Evolutionary Rates in SARS-CoV-2 and PH1N1 Influenza. Mol. Biol. Evol. 2022;39:msac009. doi: 10.1093/molbev/msac009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msac009</ArticleId><ArticleId IdType="pmc">PMC8826518</ArticleId><ArticleId IdType="pubmed">35038728</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes E.C. Patterns of Intra- and Interhost Nonsynonymous Variation Reveal Strong Purifying Selection in Dengue Virus. J. Virol. 2003;77:11296–11298. doi: 10.1128/JVI.77.20.11296-11298.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.77.20.11296-11298.2003</ArticleId><ArticleId IdType="pmc">PMC224983</ArticleId><ArticleId IdType="pubmed">14512579</ArticleId></ArticleIdList></Reference><Reference><Citation>Riemersma K.K., Coffey L.L. Chikungunya Virus Populations Experience Diversity- Dependent Attenuation and Purifying Intra-Vector Selection in Californian Aedes Aegypti Mosquitoes. PLOS Neglected Trop. Dis. 2019;13:e0007853. doi: 10.1371/journal.pntd.0007853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0007853</ArticleId><ArticleId IdType="pmc">PMC6894883</ArticleId><ArticleId IdType="pubmed">31751338</ArticleId></ArticleIdList></Reference><Reference><Citation>Krachmarova E., Petkov P., Lilkova E., Ilieva N., Rangelov M., Todorova N., Malinova K., Hristova R., Nacheva G., Gospodinov A., et al. Insights into the SARS-CoV-2 ORF6 Mechanism of Action. Int. J. Mol. Sci. 2023;24:11589. doi: 10.3390/ijms241411589.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241411589</ArticleId><ArticleId IdType="pmc">PMC10380535</ArticleId><ArticleId IdType="pubmed">37511350</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos-Mendoza T. The Envelope (E) Protein of SARS-CoV-2 as a Pharmacological Target. Viruses. 2023;15:1000. doi: 10.3390/v15041000.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15041000</ArticleId><ArticleId IdType="pmc">PMC10143767</ArticleId><ArticleId IdType="pubmed">37112980</ArticleId></ArticleIdList></Reference><Reference><Citation>Bueno S.M., Abarca K., González P.A., Gálvez N.M.S., Soto J.A., Duarte L.F., Schultz B.M., Pacheco G.A., González L.A., Vázquez Y., et al. Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile. Clin. Infect. Dis. 2022;75:E792–E804. doi: 10.1093/cid/ciab823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab823</ArticleId><ArticleId IdType="pmc">PMC9402626</ArticleId><ArticleId IdType="pubmed">34537835</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte L.F., Gálvez N.M.S., Iturriaga C., Melo-González F., Soto J.A., Schultz B.M., Urzúa M., González L.A., Vázquez Y., Ríos M., et al. Immune Profile and Clinical Outcome of Breakthrough Cases after Vaccination with an Inactivated SARS-CoV-2 Vaccine. Front. Immunol. 2021;12:742914. doi: 10.3389/fimmu.2021.742914.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.742914</ArticleId><ArticleId IdType="pmc">PMC8511644</ArticleId><ArticleId IdType="pubmed">34659237</ArticleId></ArticleIdList></Reference><Reference><Citation>Giovanetti M., Slavov S.N., Fonseca V., Wilkinson E., Tegally H., Patané J.S.L., Viala V.L., San E.J., Rodrigues E.S., Santos E.V., et al. Genomic Epidemiology of the SARS-CoV-2 Epidemic in Brazil. Nat. Microbiol. 2022;7:1490–1500. doi: 10.1038/s41564-022-01191-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-022-01191-z</ArticleId><ArticleId IdType="pmc">PMC9417986</ArticleId><ArticleId IdType="pubmed">35982313</ArticleId></ArticleIdList></Reference><Reference><Citation>Trombetta C.M., Piccini G., Pierleoni G., Leonardi M., Dapporto F., Marchi S., Andreano E., Paciello I., Benincasa L., Lovreglio P., et al. Immune Response to SARS-CoV-2 Omicron Variant in Patients and Vaccinees Following Homologous and Heterologous Vaccinations. Commun. Biol. 2022;5:903. doi: 10.1038/s42003-022-03849-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-022-03849-0</ArticleId><ArticleId IdType="pmc">PMC9439265</ArticleId><ArticleId IdType="pubmed">36056181</ArticleId></ArticleIdList></Reference><Reference><Citation>Girl P., von Buttlar H., Mantel E., Antwerpen M.H., Wölfel R., Müller K. Comparative Analysis of Vaccine-Induced Neutralizing Antibodies against the Alpha, Beta, Delta, and Omicron Variants of SARS-CoV-2. Vaccines. 2024;12:515. doi: 10.3390/vaccines12050515.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines12050515</ArticleId><ArticleId IdType="pmc">PMC11126034</ArticleId><ArticleId IdType="pubmed">38793766</ArticleId></ArticleIdList></Reference><Reference><Citation>Feikin D.R., Higdon M.M., Abu-Raddad L.J., Andrews N., Araos R., Goldberg Y., Groome M.J., Huppert A., O’Brien K.L., Smith P.G., et al. Duration of Effectiveness of Vaccines against SARS-CoV-2 Infection and COVID-19 Disease: Results of a Systematic Review and Meta-Regression. Lancet. 2022;399:924–944. doi: 10.1016/S0140-6736(22)00152-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00152-0</ArticleId><ArticleId IdType="pmc">PMC8863502</ArticleId><ArticleId IdType="pubmed">35202601</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Beltran W.F., Lam E.C., St. Denis K., Nitido A.D., Garcia Z.H., Hauser B.M., Feldman J., Pavlovic M.N., Gregory D.J., Poznansky M.C., et al. Multiple SARS-CoV-2 Variants Escape Neutralization by Vaccine-Induced Humoral Immunity. Cell. 2021;184:2372–2383.e9. doi: 10.1016/j.cell.2021.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.03.013</ArticleId><ArticleId IdType="pmc">PMC7953441</ArticleId><ArticleId IdType="pubmed">33743213</ArticleId></ArticleIdList></Reference><Reference><Citation>Planas D., Bruel T., Grzelak L., Guivel-Benhassine F., Staropoli I., Porrot F., Planchais C., Buchrieser J., Rajah M.M., Bishop E., et al. Sensitivity of Infectious SARS-CoV-2 B.1.1.7 and B.1.351 Variants to Neutralizing Antibodies. Nat. Med. 2021;27:917–924. doi: 10.1038/s41591-021-01318-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01318-5</ArticleId><ArticleId IdType="pubmed">33772244</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>